[{"uuid": "b16685ba-389e-33fe-a928-8e5e9d629e13", "title": "Premier Family Dental Clinic, DNTL Hub Recognized as 2025 Top Patient Rated Dentist by Find Local Doctors", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/premier-family-dental-clinic-dntl-190000459.html", "providerPublishTime": 1737399600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/l8jC7OhhQJ.4RgGUFqBxnA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a0142f8120306f39aefbe18eb3fb1904", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z64b8tP4GE6JkHo3xviFug--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a0142f8120306f39aefbe18eb3fb1904", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "d274712b-9b84-3e43-b42e-170aae471877", "title": "Galectin Therapeutics to Present at the 2025 MASH-TAG Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/galectin-therapeutics-present-2025-mash-130000482.html", "providerPublishTime": 1736514000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VzVenswBx9K1xT0RfWwOsg--~B/aD02NTt3PTI2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 267, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9_tnV8a_Ku9cmV_TiX4Ukg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GALT"]}, {"uuid": "54aaa2d9-990e-360f-a28f-5c8e191b1a5f", "title": "Lodi Year in Review, Part 3", "publisher": "Lodi News-Sentinel, Calif.", "link": "https://finance.yahoo.com/m/54aaa2d9-990e-360f-a28f-5c8e191b1a5f/lodi-year-in-review%2C-part-3.html", "providerPublishTime": 1735880340, "type": "STORY"}, {"uuid": "acaa1127-a8e4-3475-ac09-ce71877cd823", "title": "Lodi Year in Review 2024, Part 1", "publisher": "Lodi News-Sentinel, Calif.", "link": "https://finance.yahoo.com/m/acaa1127-a8e4-3475-ac09-ce71877cd823/lodi-year-in-review-2024%2C.html", "providerPublishTime": 1735678320, "type": "STORY"}, {"uuid": "1260cc61-8cc5-397b-bb50-b4c006902aa8", "title": "Despite losing tough tiebreaker, Rodriguez still lands on Galt Council", "publisher": "Lodi News-Sentinel, Calif.", "link": "https://finance.yahoo.com/m/1260cc61-8cc5-397b-bb50-b4c006902aa8/despite-losing-tough.html", "providerPublishTime": 1734641460, "type": "STORY"}, {"uuid": "143cd983-87d7-37c3-ae8b-4f5dd5c67386", "title": "Galectin's Belapectin Study Shows Mixed Endpoint Results; Shares Fall Pre-Bell", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/galectin-apos-belapectin-study-shows-141002440.html", "providerPublishTime": 1734703802, "type": "STORY", "relatedTickers": ["GALT"]}, {"uuid": "89e741ce-54fb-3d43-b0d9-220925546f24", "title": "Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/heres-why-galectin-therapeutics-galt-143506667.html", "providerPublishTime": 1733754906, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/p7XlvorZm6LARMpstyEGHA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GALT"]}, {"uuid": "4ce11dc8-8cee-37ba-a6e8-76db8f6c03e6", "title": "Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/galectin-therapeutics-announces-top-line-130000165.html", "providerPublishTime": 1734699600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VzVenswBx9K1xT0RfWwOsg--~B/aD02NTt3PTI2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 267, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9_tnV8a_Ku9cmV_TiX4Ukg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GALT"]}, {"uuid": "aeb0f2e4-0df0-34b9-a585-7f4bc8c6d36b", "title": "Top Midday Decliners", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-midday-decliners-191628936.html", "providerPublishTime": 1734722188, "type": "STORY", "relatedTickers": ["CYN", "GALT"]}, {"uuid": "f26bb47e-3929-3be5-8d24-889365d523a1", "title": "Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/galectin-therapeutics-reports-financial-results-130000659.html", "providerPublishTime": 1731589200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VzVenswBx9K1xT0RfWwOsg--~B/aD02NTt3PTI2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 267, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9_tnV8a_Ku9cmV_TiX4Ukg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GALT"]}, {"uuid": "0f0c7124-eb9d-3866-8728-a00fcd184b82", "title": "Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics\u2019 govorestat", "publisher": "Pharmaceutical Technology", "link": "https://finance.yahoo.com/m/0f0c7124-eb9d-3866-8728-a00fcd184b82/wait-for-galactosemia-therapy.html", "providerPublishTime": 1732795365, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/DMXgLtevazkPBHsxXDKjjw--~B/aD01NjI7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/2164b941606b1e321246f29d83ae7a74", "width": 1000, "height": 562, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/jFeBJ5EFE27rCLtiRnkHIQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/2164b941606b1e321246f29d83ae7a74", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLT"]}, {"uuid": "9f47a547-4d9f-3981-abfa-16ce3767b4b3", "title": "Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/galectin-therapeutics-presents-three-abstracts-130000422.html", "providerPublishTime": 1731934800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VzVenswBx9K1xT0RfWwOsg--~B/aD02NTt3PTI2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 267, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9_tnV8a_Ku9cmV_TiX4Ukg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/089af21c6219080c2660263701842b67", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GALT"]}, {"uuid": "cd7609f7-3df8-3461-ab4f-a80ae533bb12", "title": "Net-Trade Ventures Launches Crowdfunding Campaign to Fund Innovative Automated Valuation Model (AVM) for Net Lease Market", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/net-trade-ventures-launches-crowdfunding-135900305.html", "providerPublishTime": 1731938340, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PA_YrZwG9N4uje.IKfg2ww--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/2c9a2aec03b7b0cc756a5162fad945de", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TTMs_Y7URwYrEwS51nmqvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/2c9a2aec03b7b0cc756a5162fad945de", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "1579e4b0-1765-35f8-8334-6b245294692a", "title": "Oak View Elementary School unveils mural in memory of longtime staffer", "publisher": "Lodi News-Sentinel, Calif.", "link": "https://finance.yahoo.com/m/1579e4b0-1765-35f8-8334-6b245294692a/oak-view-elementary-school.html", "providerPublishTime": 1731531120, "type": "STORY"}, {"uuid": "5c2c2d20-015e-3445-9d68-ddac649a040c", "title": "Jess Loseke, CEO of Midwest Barrel Co., Named One of Louisville's \"Most Admired CEOs\"", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/jess-loseke-ceo-midwest-barrel-143200753.html", "providerPublishTime": 1731421920, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9oxTe2mnRney2RXOuhFo_A--~B/aD00MDA7dz0zOTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ac1e2878016e225d1094cf1e1f59b4c2", "width": 397, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/rQ5myngsFLqO_JciQ3sIBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ac1e2878016e225d1094cf1e1f59b4c2", "width": 140, "height": 140, "tag": "140x140"}]}}]